{
  "ptid_time": "036_S_0748_2006-08-10",
  "img_path": "/data/qiuhui/data/adni/images/036_S_0748/2006-08-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 73,216 mm³, 90.1% above the reference mean. With a Z-score of 2.16 (98.5th percentile), this represents significant enlargement; hippocampal volume measures 6,128 mm³, 18.9% below the reference mean. With a Z-score of -1.85 (3.2th percentile), this represents moderate atrophy; whole brain volume measures 1,156,430 mm³, 7.1% above the reference mean. With a Z-score of 0.93 (82.3th percentile), this represents normal volume ; entorhinal cortex volume measures 3,143 mm³, 23.4% below the reference mean. With a Z-score of -1.58 (5.7th percentile), this represents moderate atrophy; fusiform gyrus volume measures 14,652 mm³, 22.2% below the reference mean. With a Z-score of -1.89 (2.9th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 23,365 mm³, 9.5% above the reference mean. With a Z-score of 0.85 (80.3th percentile), this represents normal volume . ",
  "text_data": "Age is 79.6 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Psychiatric; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Gastrointestinal; Allergies or Drug Sensitivities; Smoking; Major Surgical Procedures. MMSE: 26.0. Logical Memory: 2.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 520.80 pg/mL (mild reduced); Total tau: 169.30 pg/mL (normal ); Phosphorylated tau: 16.76 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant ventricular enlargement (consistent with atrophy) and moderate atrophy in the hippocampus, entorhinal cortex, and fusiform gyrus—key regions affected in Alzheimer’s disease. The MMSE score of 26 is borderline (mild cognitive impairment range), and the presence of one APOE4 allele with mildly reduced Aβ supports early neurodegenerative changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology)  \n**Confidence:** **Medium** (clinical correlation needed to rule out other causes of atrophy, but biomarker and structural findings align with early AD progression).",
  "timestamp": "2025-07-26T06:04:09.087091"
}